PRA9 COSTS AND BENEFITS ASSOCIATED WITH ADDITION OF SALMETEROL VERSUS MONTELUKAST TO INHALED CORTICOSTEROID THERAPY IN A MEDICAID ASTHMATIC POPULATION
R Balkrishnan, F Camacho, MS Schechter, RA Pleasants, DL BowtonVolume:
5
Year:
2002
Language:
english
DOI:
10.1016/s1098-3015(10)60983-7
File:
PDF, 78 KB
english, 2002